Jing Guo

发表

Advances in protein kinase drug discovery through targeting gatekeeper mutations

Xiaoyun Lu, Jing Guo, Yang Zhou, 2023, Expert opinion on drug discovery.

Structure-Based Optimization of Pyrazinamide-Containing Macrocyclic Derivatives as Fms-like Tyrosine Kinase 3 (FLT3) Inhibitors to Overcome Clinical Mutations.

Zhang Zhang, Zhi-Min Zhang, Yang Zhou, 2024, ACS pharmacology & translational science.